Effects of daily hemodialysis on heart rate variability: Results from the Frequent Hemodialysis Network (FHN) Daily Trial

Nephrology Dialysis Transplantation

Volumn 29, Issue 1, 2014, Pages 168-178

  Chan, Christopher T ^a   Chertow, Glenn M ^b   Daugirdas, John T ^c   Greene, Tom H ^d   Kotanko, Peter ^e   Larive, Brett ^f   Pierratos, Andreas ^a   Stokes, John B ^g  

^a UNIVERSITY HEALTH NETWORK   (Canada)

^b STANFORD UNIVERSITY   (United States)

^c UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

^d UNIVERSITY OF UTAH   (United States)

^e RENAL RESEARCH INSTITUTE   (United States)

^f LERNER RESEARCH INSTITUTE   (United States)

^g UNIVERSITY OF IOWA   (United States)

Author keywords

daily hemodialysis; end stage renal disease; frequent hemodialysis network; heart rate variability; left ventricular mass

Indexed keywords

ADULT; AGE; ARTICLE; CARDIOVASCULAR EFFECT; CONTROLLED STUDY; DIABETES MELLITUS; FEMALE; HEART LEFT VENTRICLE MASS; HEART RATE; HEART RATE VARIABILITY; HEMODIALYSIS; HOLTER MONITORING; HUMAN; INTERMETHOD COMPARISON; KIDNEY FAILURE; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SYMPATHETIC TONE; THERAPY EFFECT; TREATMENT OUTCOME; TREATMENT RESPONSE;

DAILY HEMODIALYSIS; END-STAGE RENAL DISEASE; FREQUENT HEMODIALYSIS NETWORK; HEART RATE VARIABILITY; LEFT VENTRICULAR MASS;

ADULT; AGED; ELECTROCARDIOGRAPHY, AMBULATORY; FEMALE; HEART; HEART RATE; HUMANS; HYPERTROPHY, LEFT VENTRICULAR; KIDNEY FAILURE, CHRONIC; MALE; MIDDLE AGED; RENAL DIALYSIS; SYMPATHETIC NERVOUS SYSTEM;

EID: 84892762859     PISSN: 09310509     EISSN: 14602385     Source Type: Journal    
DOI: 10.1093/ndt/gft212     Document Type: Article

References (35)

1. Foley RN. Clinical epidemiology of cardiac disease in dialysis patients: left ventricular hypertrophy, ischemic heart disease, and cardiac failure. Semin Dial 2003; 16: 111-117
2. Ranpuria R, Hall M, Chan CT et al. Heart rate variability (HRV) in kidney failure: measurement and consequences of reduced HRV. Nephrol Dial Transplant 2008; 23: 444-449
3. La Rovere MT, Bigger JT, Jr, Marcus FI et al. Baroreflex sensitivity and heart-rate variability in prediction of total cardiac mortality after myocardial infarction. ATRAMI (autonomic tone and reflexes after myocardial infarction) Investigators. Lancet 1998; 351: 478-484
4. Chan CT. Heart rate variability in patients with end-stage renal disease: an emerging predictive tool for sudden cardiac death? Nephrol Dial Transplant 2008; 23: 3061-3062
5. Hausberg M, Kosch M, Harmelink P et al. Sympathetic nerve activity in end-stage renal disease. Circulation 2002; 106: 1974-1979
6. Chertow GM, Levin NW, Beck GJ et al. In-center hemodialysis six times per week versus three times per week. N Engl J Med 2010; 363: 2287-2300
7. Suri RS, Garg AX, Chertow GM et al. Frequent Hemodialysis Network (FHN) randomized trials: study design. Kidney Int 2007; 71: 349-359
8. Chan CT, Levin NW, Chertow GM et al. Determinants of cardiac autonomic dysfunction in ESRD. Clin J Am Soc Nephrol 2010; 5: 1821-1827
9. Lorenzi-Filho G, Dajani HR, Leung RS et al. Entrainment of blood pressure and heart rate oscillations by periodic breathing. Am J Respir Crit Care Med 1999; 159: 1147-1154
10. Fieno DS, Jaffe WC, Simonetti OP et al. TrueFISP: assessment of accuracy for measurement of left ventricular mass in an animal model. J Magn Reson Imaging 2002; 15: 526-531
11. DuBois D, DuBois EF. A formula to estimate the approximate surface area if height and weight be known. Arch Intern Med. 1916; 17: 863-871
12. Watson PE, Watson ID, Batt RD. Total body water volumes for adult males and females estimated from simple anthropometric measurements. Am J Clin Nutr 1980; 33: 27-39
13. Alfakih K, Plein S, Thiele H et al. Normal human left and right ventricular dimensions for MRI as assessed by turbo gradient echo and steady-state free precession imaging sequences. J Magn Reson Imaging 2003; 17: 323-329
14. Guralnik JM, Ferrucci L, Pieper CF et al. Lower extremity function and subsequent disability: consistency across studies, predictive models, and value of gait speed alone compared with the short physical performance battery. J Gerontol A Biol Sci Med Sci 2000; 55: M221-M231
15. Kotler DP, Tierney AR, Wang J et al. Magnitude of body-cell-mass depletion and the timing of death from wasting in AIDS. Am J Clin Nutr 1989; 50: 444-447
16. Wang Z, St-Onge MP, Lecumberri B et al. Body cell mass: model development and validation at the cellular level of body composition. Am J Physiol Endocrinol Metab 2004; 286: E123-E128
17. Little RJA, Rubin DB. Statistical analysis with missing data. New York: Hoboken, NJ: J Wiley & Sons, 2002
18. Rubinger D, Revis N, Pollak A et al. Predictors of haemodynamic instability and heart rate variability during haemodialysis. Nephrol Dial Transplant 2004; 19: 2053-2060
19. Rubinger D, Sapoznikov D, Pollak A et al. Heart rate variability during chronic hemodialysis and after renal transplantation: studies in patients without and with systemic amyloidosis. J Am Soc Nephrol 1999; 10: 1972-1981
20. Floras JS. Clinical aspects of sympathetic activation and parasym-pathetic withdrawal in heart failure. J Am Coll Cardiol 1993; 22: 72A-84A
21. La Rovere MT, Pinna GD, Hohnloser SH et al. Baroreflex sensitivity and heart rate variability in the identification of patients at risk for life-threatening arrhythmias: implications for clinical trials. Circulation 2001; 103: 2072-2077
22. Oikawa K, Ishihara R, Maeda T et al. Prognostic value of heart rate variability in patients with renal failure on hemodialysis. Int J Cardiol 2009; 131: 370-377
23. Nishimura M, Tokoro T, Nishida M et al. Sympathetic overactiv-ity and sudden cardiac death among hemodialysis patients with left ventricular hypertrophy. Int J Cardiol, 2010; 142: 80-86
24. Zilch O, Vos PF, Oey PL et al. Sympathetic hyperactivity in hae-modialysis patients is reduced by short daily haemodialysis. J Hy-pertens 2007; 25: 1285-1289
25. Nolan RP, Jong P, Barry-Bianchi SM et al. Effects of drug, biobe-havioral and exercise therapies on heart rate variability in coronary artery disease: a systematic review. Eur J Cardiovasc Prev Rehabil 2008; 15: 386-396
26. Zoccali C, Mallamaci F, Parlongo S et al. Plasma norepinephrine predicts survival and incident cardiovascular events in patients with end-stage renal disease. Circulation 2002; 105: 1354-1359
27. Schlaich MP, Socratous F, Hennebry S et al. Sympathetic activation in chronic renal failure. J Am Soc Nephrol 2009; 20: 933-939
28. Simpson P, McGrath A, Savion S. Myocyte hypertrophy in neonatal rat heart cultures and its regulation by serum and by cat-echolamines. Circ Res 1982; 51: 787-801
29. Zoccali C, Mallamaci F, Tripepi G et al. Norepinephrine and concentric hypertrophy in patients with end-stage renal disease. Hypertension 2002; 40: 41-46
30. Nishimura M, Hashimoto T, Kobayashi H et al. Association between cardiovascular autonomic neuropathy and left ventricular hypertrophy in diabetic haemodialysis patients. Nephrol Dial Transplant 2004; 19: 2532-2538
31. Chan CT, Greene T, Chertow GM et al. Determinants of left ventricular mass in patients on hemodialysis: frequent hemodialysis network (FHN) Trials. Circ Cardiovasc Imaging 2012; 5: 251-261
32. Horner SM, Murphy CF, Coen B et al. Contribution to heart rate variability by mechanoelectric feedback. Stretch of the sinoatrial node reduces heart rate variability. Circulation 1996; 94: 1762-1767
33. Gomes ME, Aengevaeren WR, Lenders JW et al. Improving myo-cardial perfusion by percutaneous coronary intervention reduces central sympathetic activity instable angina. Clin Cardiol 2012; 33: E16-E21
34. Burton JO, Jefferies HJ, Selby NM et al. Hemodialysis-induced repetitive myocardial injury results in global and segmental reduction in systolic cardiac function. Clin J Am Soc Nephrol 2009; 4: 1925-1931
35. Jefferies HJ, Virk B, Schiller B et al. Frequent emodialysis schedules are associated with reduced levels of dialysis-induced cardiac injury (myocardial stunning). Clin J Am Soc Nephrol 2011; 6: 1326-1332